ARTIVION, INC. (AORT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 106.93M USD | Liabilities, Current |
| Cash and equivalents | 77.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 97.93M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 103.36M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $106.93M | $77.32M | (m) | $97.93M | $103.36M | (m) |
| 2026-03-31 | (m) | $92.70M | $55.76M | (m) | $91.87M | $98.00M | (m) |
| 2025-12-31 | (m) | $101.56M | $64.91M | (m) | $89.76M | $92.43M | (m) |
| 2025-09-30 | (m) | $85.84M | $73.43M | (m) | $88.11M | $90.55M | (m) |
| 2025-06-30 | (m) | $66.67M | $53.48M | (m) | $91.44M | $86.72M | (m) |
| 2025-03-31 | (m) | $51.94M | $37.69M | (m) | $87.80M | $81.93M | (m) |
| 2024-12-31 | (m) | $66.82M | $53.46M | (m) | $79.46M | $79.77M | (m) |
| 2024-09-30 | (m) | $152.84M | $56.17M | (m) | $75.69M | $84.12M | (m) |
| 2024-06-30 | (m) | $50.58M | $55.02M | (m) | $73.89M | $80.80M | (m) |
| 2024-03-31 | (m) | $45.83M | $51.12M | (m) | $74.30M | $81.72M | (m) |
| 2023-12-31 | (m) | $57.86M | $58.94M | (m) | $71.80M | $81.98M | (m) |
| 2023-09-30 | (m) | $54.96M | $53.48M | (m) | $64.28M | $78.79M | (m) |
| 2023-06-30 | (m) | $56.23M | $48.77M | (m) | $64.81M | $78.46M | (m) |
| 2023-03-31 | (m) | $43.96M | $30.77M | (m) | $62.76M | $76.27M | (m) |
| 2022-12-31 | (m) | $49.67M | $39.35M | (m) | $61.82M | $74.48M | (m) |
| 2022-09-30 | (m) | $45.99M | $37.57M | (m) | $57.16M | $73.04M | (m) |
| 2022-06-30 | (m) | $41.65M | $40.38M | (m) | $57.56M | $74.32M | (m) |
| 2022-03-31 | (m) | $42.84M | $51.41M | (m) | $55.00M | $76.21M | (m) |
| 2021-12-31 | (m) | $44.95M | $55.01M | (m) | $53.02M | $76.97M | (m) |
| 2021-09-30 | (m) | $61.13M | $64.59M | (m) | $49.68M | $78.32M | (m) |
| 2021-06-30 | (m) | $58.94M | $50.47M | (m) | $49.67M | $76.36M | (m) |
| 2021-03-31 | (m) | $58.02M | $56.55M | (m) | $48.32M | $73.38M | (m) |
| 2020-12-31 | (m) | $60.47M | $61.41M | (m) | $45.96M | $73.04M | (m) |
| 2020-09-30 | (m) | $53.67M | $64.12M | (m) | $46.91M | $69.40M | (m) |
| 2020-06-30 | (m) | $48.93M | $125.63M | (m) | $45.22M | $62.71M | (m) |
| 2020-03-31 | (m) | $43.69M | $63.38M | (m) | $48.72M | $54.30M | (m) |
| 2019-12-31 | (m) | $45.20M | $33.77M | (m) | $52.94M | $53.07M | (m) |
| 2019-09-30 | (m) | $42.19M | $36.69M | (m) | $50.55M | $48.40M | (m) |
| 2019-06-30 | (m) | $37.47M | $39.75M | (m) | $54.77M | $45.42M | (m) |
| 2019-03-31 | (m) | $36.42M | $40.34M | (m) | (m) | $44.12M | (m) |
| 2018-12-31 | (m) | $34.52M | $41.49M | (m) | $47.11M | $45.48M | (m) |
| 2018-09-30 | (m) | $30.75M | $34.56M | (m) | (m) | $46.15M | (m) |
| 2018-06-30 | (m) | $34.12M | $24.96M | (m) | (m) | $45.79M | (m) |
| 2018-03-31 | (m) | $32.89M | $26.58M | (m) | (m) | $44.59M | (m) |
| 2017-12-31 | (m) | $42.94M | $39.98M | (m) | $47.52M | $46.68M | (m) |
| 2017-09-30 | (m) | $26.11M | $54.24M | (m) | (m) | $27.76M | (m) |
| 2017-06-30 | (m) | $25.77M | $52.51M | (m) | (m) | $26.54M | (m) |
| 2017-03-31 | (m) | $28.15M | $58.88M | (m) | (m) | $25.80M | (m) |
| 2016-12-31 | (m) | $30.10M | $56.64M | (m) | $27.77M | $26.29M | (m) |
| 2016-09-30 | (m) | $24.76M | $54.13M | (m) | (m) | $25.53M | (m) |
| 2016-06-30 | (m) | $24.74M | $46.94M | (m) | (m) | $25.39M | (m) |
| 2016-03-31 | (m) | $24.84M | $44.83M | (m) | (m) | $25.29M | (m) |
| 2015-12-31 | (m) | $19.61M | $37.59M | (m) | $23.42M | $14.64M | (m) |
| 2015-09-30 | (m) | $22.23M | $38.50M | (m) | (m) | $14.43M | (m) |
| 2015-06-30 | (m) | $19.19M | $35.08M | (m) | (m) | $13.51M | (m) |
| 2015-03-31 | (m) | $17.20M | $32.41M | (m) | (m) | $13.51M | (m) |
| 2014-12-31 | (m) | $20.63M | $33.38M | (m) | $21.06M | $12.74M | (m) |
| 2014-09-30 | (m) | $20.00M | $29.82M | (m) | (m) | $13.16M | (m) |
| 2014-06-30 | (m) | $19.13M | $30.87M | (m) | (m) | $12.09M | (m) |
| 2014-03-31 | (m) | $18.36M | $32.76M | (m) | (m) | $11.49M | (m) |
| 2013-12-31 | (m) | $20.72M | $37.64M | (m) | $17.84M | $9.77M | (m) |
| 2013-09-30 | (m) | $20.23M | $17.68M | (m) | (m) | $10.21M | (m) |
| 2013-06-30 | (m) | $18.82M | $11.73M | (m) | (m) | $10.84M | (m) |
| 2013-03-31 | (m) | $16.58M | $8.63M | (m) | $19.88M | $10.21M | (m) |
| 2012-12-31 | (m) | $21.43M | $13.01M | (m) | $15.94M | $10.56M | (m) |
| 2012-09-30 | (m) | $19.86M | $7.79M | (m) | $17.32M | $10.25M | (m) |
| 2012-06-30 | (m) | $24.83M | $4.00M | (m) | $17.41M | $9.67M | (m) |
| 2012-03-31 | (m) | $20.80M | $21.15M | (m) | (m) | $7.93M | (m) |
| 2011-12-31 | (m) | $21.46M | $21.70M | (m) | $15.77M | $7.32M | (m) |
| 2011-09-30 | (m) | $22.28M | $21.05M | (m) | (m) | $7.00M | (m) |
| 2011-06-30 | (m) | $19.86M | $19.80M | (m) | (m) | $6.22M | (m) |
| 2011-03-31 | (m) | (m) | $37.58M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $19.33M | $35.50M | (m) | (m) | $6.43M | (m) |
| 2010-09-30 | (m) | (m) | $31.00M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $36.14M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $30.12M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $17.20M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |